Saudi Arabia's cabinet announced August 15th the establishment of the Saudi National Institute of Health (SNIH). Aiming to facilitate medical research and clinical trials on a national scope.
The institute will oversee and support all translational research and clinical trials, Minister of Health Fahad Aljalajel said. It will gain added value from research by transforming the results into health and economic benefits to raise the quality of life.
Aljalajel added that the institute will aid in the prevention of health emergencies; one of the goals of Vision 2030 and the Health Sector Transformation Program. This will be achieved through research, development, and innovation to improve health policies and strategies, he said.
SNIH will contribute to raising national income by developing locally manufactured products for prevention, diagnosis, and treatment.
“The Cabinet’s decision to establish the SINH has been made to support health sector researchers and creative competencies in translational research and clinical trials to improve the health sector in Saudi Arabia,” Aljalajel stated.
The institute helps pharmaceutical and medical device manufacturers to develop innovative products.
Furthermore, it will reduce overall healthcare costs, by attracting global investors and raising research funding.
SNIH is one of the Health Sector Transformation Program initiatives, launched with Saudi Vision 2030. Proceeded by launching the Saudi Patient Safety Center, the National Public Health Laboratory, and the National Health Emergency Operations Center.